Syracuse

Drug survival and post-drug survival of systemic treatments in a national French cohort of children with atopic dermatitis

Archive ouverte

Chambrelan, E | Barbarot, Sébastien | Bekel, L | Poizeau, F | Mahé, E | Puzenat, E | Delaunay, J | Mallet, S | Bessis, D | Maruani, A | Miquel, J | Raison-Peyron, N | Abasq, C | Phan, A | Du Thanh, A | Kupfer, I | Bonniaud, B | Bouzille, G | Dupuy, A | Droitcourt, C

Edité par CCSD ; Wiley -

International audience. Systemic immunosuppressive treatments (IS) are restricted to severe atopic dermatitis (AD) in children. We described the IS use (first and second-line) for children with AD in a French retrospective national cohort, by using two survival analyses 'drug survival' (DS, defined as the duration of treatment) and 'post-drug survival' (PDS, defined as the time between the end of first-line and the beginning of second-line).

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion